New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 27, 2012
07:37 EDTSQNM, CI, AETNew guidelines on Sequenom test to be considered by insurers, WP says
New prenatal tests for genetic defects that require only a sample of the mother’s blood, as opposed to an invasive procedure, have come under scrutiny from major insurance companies for their high cost and limited data on accuracy and impact on care, reported The Washington Post. A new opinion from the The American College of Obstetricians and Gynecologists will be considered by insurers including Cigna (CI) and Aetna (AET) but is not considered "a clear endorsement” of the tests offered by Sequenom (SQNM) and others, according to the report. Reference Link
News For SQNM;CI;AET From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 15, 2014
13:52 EDTAETAetna will not renew contract for Delaware Medicaid program
Subscribe for More Information
October 14, 2014
10:01 EDTCIOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:40 EDTCICigna downgraded at Sterne Agee
Subscribe for More Information
05:49 EDTCICigna downgraded to Neutral from Buy at Sterne Agee
Subscribe for More Information
October 9, 2014
08:03 EDTAETWellPoint named top Managed Care pick at Jefferies
Subscribe for More Information
October 7, 2014
10:18 EDTSQNMHigh option volume stocks
Subscribe for More Information
09:24 EDTSQNMMaxim recommends buying Sequenom
Subscribe for More Information
09:01 EDTSQNMSequenom acquisition a strategic positive, says Maxim
Subscribe for More Information
07:12 EDTCICigna price target raised to $110 from $95 at JPMorgan
Subscribe for More Information
October 6, 2014
16:33 EDTSQNMSequenom acquires noninvasive prenatal testing intellectual property for $14.55M
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use